Planning & operations

Plan stability and retain samples without hiding commercial consumption

By NextEdge LabsUpdated 7 min read

For Stability coordinators and inventory leads · Plan implementation

TL;DR — what you’ll learn

  • Reserve sample quantities against their approved purpose, protocol and future pull schedule.
  • Keep stability samples, reference samples and retention samples distinguishable even when they use similar packs.
  • Record every transfer, pull, additional test and approved destruction so sample stock reconciles to physical quantities.
  • Check future commitments before releasing any apparent surplus, and test the workflow with a protocol change and an unavailable chamber.

Future pulls are already a stock commitment

A batch is released and its commercial inventory looks sufficient. Months later, the stability team requests packs for a planned time point, but the available quantity has already been allocated to customers. The study was known; its future consumption was simply absent from the inventory plan.

Stability sample inventory management should reserve the required quantities when the approved study and sampling decisions are established. The reservation needs to identify the product, batch, pack, storage condition, time point and purpose. A single deduction labelled “QC samples” (quality control samples) loses the information needed to protect later pulls.

The same principle applies to samples held for other purposes, but the requirements are not interchangeable. A sample reserved for a scheduled stability test should not be consumed for an unrelated investigation merely because it is physically nearby. The responsible team must assess the effect on the original obligation and authorise the change.

Separate sample purpose from physical location

A location describes where a pack is stored. A purpose describes why it must remain available and under what conditions it may be used. One room can contain several sample categories, while one study can occupy several controlled locations. Model both dimensions.

EU Annex 19 distinguishes reference samples retained for possible analysis from retention samples kept to represent the finished presentation. Those definitions concern the EU GMP context; they do not establish a universal stability protocol or replace applicable Indian and product-specific requirements. EU GMP Annex 19 on reference and retention samples.

For the operating system, assign each quantity a purpose and its governing evidence. Stability quantities should link to the approved protocol and amendment. Other retained quantities should link to the applicable retention basis and responsible owner. Avoid one default retention period or sample quantity across all products and markets.

Scroll horizontally to see all columns.

Separate sample purpose from physical location
Sample recordWhy it is needed
Product, batch and pack identityPrevents substitution between superficially similar samples
Purpose and governing documentExplains why the quantity is reserved
Condition and locationSupports retrieval and storage accountability
Planned time point and quantityProtects future scheduled consumption
Actual movement and remaining balanceEnables physical reconciliation
Restriction or exceptionIdentifies unavailable or questioned samples

Worked example of twelve planned pulls

Consider an illustrative study with twelve planned pulls, each requiring two packs. The approved requirement is therefore 12 × 2 = 24 packs. These values are assumptions for the example; actual study quantities and time points come from the approved protocol.

The batch has 1,000 packs available for allocation before sample commitments are recorded. Reserving 24 packs leaves 976 potentially available for other purposes, subject to all other restrictions and reservations. Moving the 24 packs into the study location should fulfil the reservation rather than deducting a second 24 packs from the overall balance.

After three pulls, six packs have been consumed and 18 remain for nine future pulls. The record should show both facts. A simple stock screen showing 18 packs without the remaining commitment may invite another department to treat them as surplus.

Suppose an approved additional test needs two more packs. If the team consumes them from the 18 without changing the plan, only 16 remain against 18 future committed packs. The workflow should expose a two-pack deficit before the movement is authorised, so the responsible study owner can assess the available options.

An authorised amendment may allocate two additional eligible packs from the batch, revise a scientifically justified requirement or determine another appropriate response. The inventory application cannot choose the scientific solution. Its role is to make the consequence visible and preserve the approved decision and resulting balance.

Track movements without counting them as consumption

Moving a sample between rooms or chambers changes custody and location, not necessarily quantity. A pull may remove it from storage, but the final consumption event may occur later in the laboratory. Define the states and transitions so transfers do not appear as unexplained losses.

Record dispatch and receipt for movements between sites or external laboratories. Include the sample identifier, quantity, sender, receiver and relevant handling evidence. If receipt is incomplete, retain an in-transit or discrepancy state instead of assuming the destination has the full quantity.

Opened packs and partial quantities need particular care. Whether the remaining material can support another purpose depends on the approved method, protocol and storage conditions. Do not let a generic “return to stock” transaction make an opened sample interchangeable with an unopened pack.

The sampling and inventory reconciliation guide covers the broader inventory accounting. Here, the additional requirement is preserving the future study and retention commitments attached to each sample quantity.

Plan chamber capacity as well as pack quantities

Having enough packs does not establish that there is suitable storage capacity. Represent the condition, location restrictions and occupancy period needed for the study. A planned pull reduces occupancy only when the actual movement occurs; delayed pulls can leave the location fuller than the forecast suggests.

Use the site's approved storage and monitoring arrangements. Avoid deriving product suitability from a chamber name alone. If a chamber becomes unavailable, the study owner and relevant quality specialists need to assess the affected samples, transfer options and any excursion evidence.

A transfer proposal should identify the complete affected population and the remaining time-point commitments. This helps the team avoid moving only the nearest labelled boxes while leaving other samples from the same study unaccounted for. The stability-study workflow guide addresses scheduling, testing and review beyond the inventory movement itself.

Handle amendments without rewriting the original plan

Study requirements can change through authorised amendments. Preserve the original schedule, revised schedule, reason, approval and effective date. Identify which future pulls change and whether any already completed work requires assessment.

An amendment that adds a condition or time point should create an explicit quantity and capacity impact. An amendment that removes a future pull should not automatically make the corresponding samples saleable. Their subsequent use or disposal needs an authorised decision based on the product and sample history.

Dates also carry different meanings. A planned study time point, a sample-use restriction, product expiry and an API retest date are not synonyms. The guide to API retest-date inventory explains one important distinction. Keep the applicable dates in separate fields and apply the relevant rule to the intended action.

Reconcile physical stock and future obligations together

A successful count should answer two questions: does the physical quantity match the record, and does the remaining eligible quantity cover the future commitments? A perfect physical count can still conceal a planned deficit.

Investigate differences by sample identity, purpose and location. Avoid balancing the total by moving quantities between studies without evidence. If a pack is missing, the effect may depend on the time point or retention purpose it supported, so the study owner needs more than a net stock adjustment.

For approved destruction, record the authorisation, affected sample identities, quantity, date and evidence required by the site's process. Verify that no active study, investigation, retention requirement or other hold still needs the samples. A scheduled end date should initiate review, not silently trigger irreversible disposal.

Pilot with a complete sample lifecycle

Choose one study and follow its reservation, physical transfer, first pull, laboratory consumption and reconciliation. Then test an additional-test request, a protocol amendment and an unavailable location. Confirm that the balance and future commitment remain explainable after each event.

NextEdge Labs can connect inventory, study scheduling and laboratory records around this lifecycle. The useful acceptance condition is that a coordinator can identify every remaining sample and explain which future obligation it supports without reconciling several disconnected spreadsheets.

Summary and next actions

Sample inventory should protect future obligations as well as record current packs. Purpose, protocol version, custody and remaining commitments make the difference between a countable sample store and a dependable study resource.

  • Reconcile one study's approved pull quantities with its actual reserved and stored packs.
  • Separate stability, reference and retention purposes in the inventory model.
  • Test how an additional test and a protocol amendment affect remaining commitments.
  • Require an authorised review before releasing surplus quantities or destroying samples.

Scope this automation around your operation

Tell us your current systems, transaction volume and the exception you need to resolve. We can discuss a focused first release, its review controls and how to measure the result.

START A CONVERSATION

Let’s talk about your next build.

Prepare your brief below, then review and send it in your email app to sales@nextlabsonline.com.

SELECTED INDUSTRYPharma & life sciences

Article: Plan stability and retain samples without hiding commercial consumption

THE FIRST CONVERSATION

Your product idea, AI opportunity or automation challenge—and a useful first milestone.

All fields are required.

A few sentences about the problem, your users and timing are enough.

We’ll use your details to respond to your enquiry. Please don’t include patient records, passwords or confidential information. Privacy Policy · Website Terms.

About this guide

NextEdge Labs develops software, integrations and AI-assisted workflows. This guide presents practical workflow analysis with linked source references. Worked examples are illustrative, not client results.

Apply the sources within their stated market and scope, together with your approved procedures and the decisions of the responsible specialists.

Browse all Pharma & life sciences guides or explore our engineering capabilities.